AMSTERDAM MOLECULAR THERAPEUTICS

Brand Owner Address Description
AMT AMSTERDAM MOLECULAR THERAPEUTICS (AMT) IP B.V. Meibergdreef 61 Amsterdam 1105BA Netherlands AMSTERDAM MOLECULAR THERAPEUTICS;Medical services, namely, services for gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention comprises a method for producing mammalian therapeutics free from prion contamination and cells for use in such methods. Such therapeutics are produced in somatic cells having a genome with an artificially altered PrP gene. The PrP gene in these cells may be ablated, or replaced by an exogenous inducible form of the PrP gene. The endogenous gene in the host cells may be disrupted, or disrupted and replaced by an exogenous PrP gene.